Ansvarsfraskrivelse: Denne siden kan inneholde tilknyttede lenker. CoinMarketCap kan bli kompensert hvis du besøker tilknyttede plattformer og utfører visse handlinger som å registrere deg og handle på disse plattformene. Referer til vår affiliate-erklæring.
Nyheter om Triall
Om Triall
What is Triall (TRL)?
Triall is an end-to-end digital ecosystem of blockchain-enabled software solutions for clinical trials.
The project leverages blockchain, Artificial Intelligence, and related technologies to make clinical trial processes tamper-resistant, and to enable secure and compliant connections between the many isolated systems and parties involved in clinical research.
Triall’s native TRL token enables access to ecosystem utilities, P2P compensation, governance, and community engagement.
The project is on a mission to accelerate the introduction of safe and affordable new vaccines and therapeutics into society by streamlining clinical trial operations.
Who are the founders of TRL?
Triall was founded by a group of clinical operations experts, enterprise IT specialists, and blockchain developers.
Combined, their team has managed 100+ clinical trials, co-founded 20+ business ventures, and published 250+ peer-reviewed papers on innovation in medical research. This experience has left Triall with an extensive network within clinical research and the Life Sciences at large.
Triall has built an international network of partners and a global advisory board consisting of industry experts and Key Opinion Leaders that support the project in the buildout of its blockchain-enabled ecosystem.
What makes Triall unique?
As frontrunner in the clinical trials industry, Triall applies blockchain technology to address two industry-wide needs: (1) promoting traceability and auditability of clinical trial operations, which have become increasingly complex and data-heavy; and (2) enabling secure and compliant transfer of clinical trial data between organizations and systems, thereby promoting interoperability and tackling the growing problem of data fragmentation.
Triall takes an ‘ecosystem approach’ that is unique to the clinical trials industry: by enabling secure and compliant integrations between currently isolated clinical trial software, the project aims to turn current competitors into cooperators for the benefit of faster and more-efficient clinical trials. To this end, the project leverages emerging open blockchain standards such as Decentralized Identifiers (DIDs) and Verifiable Credentials (VCs). These will shape a decentralized identity and access management infrastructure for connecting systems and their users in a secure environment.
Dagens live-pris for Triall er kr 0.047754 NOK, og det 24-timers handelsvolumet ligger på ikke tilgjengelig. Vi oppdaterer prisene våre på TRL til NOK i sanntid. Triall has no change in the last 24 hours. Rangert som nummer #2085 på CoinMarketCap, med en live markedsverdi på kr 2,023,105 NOK. Antall i omløp er 42,365,415 TRL bitcoin og et maksimalt antall er 175,000,000 TRL bitcoin.
Triall handles for øyeblikket mest på . Du finner flere oppført på vår.